NDC codes

364943 NDC codes with hospital pricing data in the network.

• NDC 58394-0636-03 — coagulation factor IX (recomb) 2,000 unit intravenous solution (355 hospitals, 592–664 samples)
• NDC 00004-2002-78 — INJECTION, CEFTRIAXONE SODIUM, PER 250 MG (6 hospitals, 421–664 samples)
• NDC 409230821 — MIDAZOLAM (PF) 5 MG/ML INJECTION SOLUTION (44 hospitals, 277–664 samples)
• NDC 409909417 — FENTANYL (PF) 50 MCG/ML INJECTION SOLUTION (26 hospitals, 358–664 samples)
• NDC 58394-0012-01 — "antihemophilic factor VIII, B-domain deleted 250 (+/-) unit Soln 1 Each KIT" (202 hospitals, 592–664 samples)
• NDC 71288-0410-81 — ENOXAPARIN 30 MG/0.3 ML SUBCUTANEOUS SYRINGE (182 hospitals, 186–663 samples)
• NDC 904656761 — 00904-6567-61 - HYDROcodone-acetaminophen 0 / 1 t (38 hospitals, 492–663 samples)
• NDC 00409-6625-35 — Sodium Bicarbonate Inj 50 mEq/50 mL Vial (UD) (123 hospitals, 645–663 samples)
• NDC 00904-5306-61 — diphenhydrAMINE 25 mg capsule (323 hospitals, 519–663 samples)
• NDC 115146853 — Lidocaine-Prilocaine Cream 2.5-2.5% (50 hospitals, 437–662 samples)
• NDC 1199401101 — PERFLUTREN LIPID MICROSPHERES 1.1 MG/ML IV SUSP REFRIGERATED (31 hospitals, 158–662 samples)
• NDC 1199401104 — PERFLUTREN LIPID MICROSPHERES 1.1 MG/ML IV SUSP REFRIGERATED (42 hospitals, 158–662 samples)
• NDC 1199401116 — PERFLUTREN LIPID MICROSPHERES 1.1 MG/ML IV SUSP REFRIGERATED (49 hospitals, 158–662 samples)
• NDC 1199401701 — PERFLUTREN LIPID MICROSPHERES RT 0.65 MG/ML IV SUSP (20 hospitals, 158–662 samples)
• NDC 1199401716 — PERFLUTREN LIPID MICROSPHERES RT 0.65 MG/ML IV SUSP (20 hospitals, 158–662 samples)
• NDC 1199401720 — PERFLUTREN LIPID MICROSPHERES RT 0.65 MG/ML IV SUSP (20 hospitals, 158–662 samples)
• NDC 67850-0022-00 — AMPICILLIN 2 GRAM SOLUTION FOR INJECTION (157 hospitals, 221–662 samples)
• NDC 409115918 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (62 hospitals, 473–662 samples)
• NDC 72603-0128-10 — PANTOPRAZOLE 40 MG INTRAVENOUS SOLUTION (178 hospitals, 364–661 samples)
• NDC 50580-0534-04 — diphenhydrAMINE 12.5 mg/5 mL Liqd 118 mL BOTTLE (151 hospitals, 598–661 samples)
• NDC 59385-0022-01 — Buprenorphine 150 mcg Film 1 Each PACKET (228 hospitals, 85–661 samples)
• NDC 76045-0203-02 — glycopyrrolate (PF) 0.4 mg/2 mL (0.2 mg/mL) Syringe 2 mL SYRINGE (105 hospitals, 85–661 samples)
• NDC 00054-3294-50a — furosemide 10 mg/mL, 4 mL Oral Soln (6 hospitals, 589–661 samples)
• NDC 61553-0705-68 — HYDROMOR/SAL 15 MG/30 ML PCA (4 hospitals, 589–661 samples)
• NDC 51079-0983-20 — Lisinopril Tab 20 mg (96 hospitals, 598–661 samples)
• NDC 00121-0950-03 — Lidocaine Soln, Viscous 2% 100 mL Bottle (98 hospitals, 598–661 samples)
• NDC 31722-0116-50 — LIDOCAINE HCL 10 MG/ML (1 %) INJECTION SOLUTION (30 hospitals, 391–661 samples)
• NDC 31722-0116-33 — LIDOCAINE HCL 1 % IJ SOLN (12 hospitals, 391–661 samples)
• NDC 17478-0062-35 — White Petrolatum-Mineral Oil 83-15 % Oint 3.5 g TUBE (304 hospitals, 633–660 samples)
• NDC 24208-0585-59 — tropicamide 1 % eye drops (182 hospitals, 561–660 samples)
• NDC 71351-0010-01 — POTASSIUM, SODIUM PHOSPHATES 280 MG-160 MG-250 MG ORAL POWDER PACKET (171 hospitals, 507–660 samples)
• NDC 00143-9744-10 — GRANISETRON HCL 1 MG/ML IV SOLN (280 hospitals, 282–660 samples)
• NDC 00409-3724-32 — DOBUTamine 1,000 mg/250 mL(4,000 mcg/mL) in 5 % dextrose IV (227 hospitals, 516–660 samples)
• NDC 143211250 — DOXYCYCLINE HYCLATE 100 MG TABLET (46 hospitals, 498–660 samples)
• NDC 904598426 — AMMONIUM LACTATE 12 % LOTION (141 hospitals, 633–660 samples)
• NDC 00121-0489-10 — DIPHENHYDRAMINE 12.5 MG/5ML ELIXIR (75 hospitals, 588–660 samples)
• NDC 00536-1303-56 — simethicone 40 mg/0.6 mL Oral Liq 0.6 mL (9 hospitals, 579–660 samples)
• NDC 55150-0123-16 — NAFCILLIN SODIUM 2 G IJ SOLR (271 hospitals, 264–660 samples)
• NDC 0641092921 — PROMETHAZINE 50 MG/ML INJECTION SOLUTION (41 hospitals, 66–660 samples)
• NDC 0641092925 — PROMETHAZINE 50 MG/ML INJECTION SOLUTION (40 hospitals, 66–660 samples)
• NDC 0641094831 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (40 hospitals, 66–660 samples)
• NDC 0641149531 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (62 hospitals, 66–660 samples)
• NDC 0641149535 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (59 hospitals, 66–660 samples)
• NDC 0641149631 — PROMETHAZINE 50 MG/ML INJECTION SOLUTION (60 hospitals, 66–660 samples)
• NDC 0641608201 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (21 hospitals, 66–660 samples)
• NDC 0641608401 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (21 hospitals, 66–660 samples)
• NDC 0641608425 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (24 hospitals, 66–660 samples)
• NDC 0641620801 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (42 hospitals, 66–660 samples)
• NDC 0641620825 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (21 hospitals, 66–660 samples)
• NDC 3982255003 — PROMETHAZINE 25 MG/ML INJECTION SOLUTION (20 hospitals, 66–660 samples)